RecruitingNot ApplicableNCT05917210

Peer-led Implementation of TB-HIV Education and Adherence Counseling in Uganda


Sponsor

Yale University

Enrollment

1,920 participants

Start Date

Mar 16, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

This cluster-randomized trial in Uganda will evaluate the effectiveness and implementation of a novel, peer-led TB education and counseling strategy to improve outcomes among persons with tuberculosis (TB) with and without HIV/AIDS and assess the social-behavioral mechanisms underlying the observed treatment effects.


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • Age ≥18 years
  • Registered as a new, relapse, treatment failure, or previously lost-to-follow-up
  • TB case according to the on-site NTP TB Treatment Register
  • Screened and invited to participate within 30 days of TB treatment initiation

Exclusion Criteria4

  • Diagnosed with possible or confirmed drug-resistant TB
  • Transferring TB care into the clinic from an off-site facility
  • Residing \>40 km from the enrolling clinic
  • Lacking mental capacity to provide informed consent

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALPeer-Navigaton TB-EC Strategy

Participants receive a peer-navigation strategy for TB education and counseling, including individual-level components such as peer navigator support, an illustrated TB-EC booklet with checklist, individualized adherence planning, and behavior-change messaging; and clinic-level components such as task-sharing with peer navigators, workflow restructuring, community of practice meetings, and implementation champions to support delivery.

BEHAVIORALUsual TB-EC Strategy

Participants receive usual TB education and counseling delivered by healthcare workers, including individual-level components such as TB-HIV education using a flipchart and use of treatment supporters; and clinic-level components such as routine TB-EC delivery by healthcare workers.


Locations(1)

Walimu

Kampala, Uganda

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05917210


Related Trials